Stephen Hull is a reimbursement advisor for NeuroEM, specializing in creating integrated market strategies for innovative technologies throughout their entire product lifecycle. Prior to his role as Sr. Vice President of Market Access, Avania, Stephen founded Hull Associates, a global market access and reimbursement strategy firm working in all major therapeutic areas across 22 markets worldwide. A staunch advocate for life-saving innovations, Stephen has dedicated his career to enhancing patient access to life-saving innovations. He has chaired committees for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Stephen holds a Master of Health Sciences degree in Health Policy from the Johns Hopkins Bloomberg School of Public Health and a Bachelor of Arts degree in International Relations, Political Science, and French from Colgate University. Based near Boston, Massachusetts, he is a sought-after speaker for US and international forums on payment systems and the reimbursement of pharmaceuticals, medical devices, and in vitro diagnostics.

LinkedIn Profile